Radiolabeled Cry1Fa Toxin Assay for Insect Receptor Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing the binding of Cry1Fa core toxin protein to insect receptors are hindered by traditional radiolabeling techniques, which result in loss of insecticidal activity and receptor binding capability, due to structural disruptions caused by iodination at tyrosine residues.
Innovation Solution
The use of a specific radiolabeling method targeting a single cysteine residue (C205) with fluorescein-5-maleimide, allowing for the preparation of a radiolabeled Cry1Fa core toxin protein that maintains its tertiary structure and binding ability to insect receptors, as demonstrated by its retention of insecticidal activity and receptor binding capacity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional radiolabeling methods using oxidized iodine isotopes are used to label Cry1Fa toxin, then the toxin can be detected through radioactivity measurement, but the toxin loses its ability to bind to insect receptors and its insecticidal activity
Solution Approach 1:
The patent applies local quality by changing the radiolabeling site from tyrosine residues (which disrupt structure) to a specific cysteine residue at position 205 in domain I. This localized modification allows radiodetection while preserving the integrity of receptor-binding domains, resolving the contradiction between detectability and functional reliability
Solution Approach 2:
The patent uses an intermediate compound (fluorescein-5-maleimide) as a mediator to attach the radioactive iodine to the toxin. This intermediate allows indirect radiolabeling through cysteine residue alkylation, avoiding direct iodination of tyrosine residues that would disrupt the toxin's tertiary structure and receptor binding capability
2Measurement precision
If traditional radiolabeling methods are used on Cry1Fa core toxin, then the toxin becomes detectable, but it loses its insecticidal activity in diet bioassays
Solution Approach 1:
The patent applies local quality by changing the radiolabeling site from tyrosine residues (which disrupt structure) to a specific cysteine residue at position 205 in domain I. This localized modification allows radiodetection while preserving the integrity of receptor-binding domains, resolving the contradiction between detectability and functional reliability
Solution Approach 2:
The patent uses an intermediate compound (fluorescein-5-maleimide) as a mediator to attach the radioactive iodine to the toxin. This intermediate allows indirect radiolabeling through cysteine residue alkylation, avoiding direct iodination of tyrosine residues that would disrupt the toxin's tertiary structure and receptor binding capability
3Reliability
If fluorescent labeling or isothermal calorimetry methods are used to measure ligand-receptor binding, then the methods avoid structural disruption, but they are either too insensitive or too difficult to use due to particulate properties of insect BBMVs
Solution Approach 1:
The patent replaces the mechanical/optical measurement systems (fluorescent labeling, isothermal calorimetry) with a radioactivity-based detection system. Radioactive detection provides superior sensitivity and is not affected by the particulate nature of insect BBMVs, while the indirect labeling method through cysteine residues preserves structural integrity, thus resolving both concerns simultaneously
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the Cry1Fa core toxin protein to bind specifically to insect receptors in a saturable manner, facilitating competitive binding assays that reveal the mechanism of resistance to Cry1Fa toxin in insect populations, such as those from Puerto Rico, by maintaining the protein's structural integrity and functional activity.
Implementation Method 1
radiolabeled Cry1Fa core toxin protein that maintains its tertiary structure and binding ability to insect receptors
Implementation Method 2
targeting a single cysteine residue (C205) with fluorescein-5-maleimide
Data Source
AI summary
Cysteine-specific radiolabeled Cry1Fa protein retains insecticidal activity against insect pests and binds to insect brush border membrane vesicle receptors in a saturable manner. The biologically-active radiolabeled Cry1Fa protein is useful in competitive binding assays with other Cry toxins.